Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $824.5 million.

  • Haemonetics' Other Gross PP&E Adjustments fell 350.72% to $824.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $824.5 million, marking a year-over-year decrease of 350.72%. This contributed to the annual value of $837.2 million for FY2025, which is 1271.75% down from last year.
  • Haemonetics' Other Gross PP&E Adjustments amounted to $824.5 million in Q4 2025, which was down 350.72% from $790.4 million recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Other Gross PP&E Adjustments peaked at $967.1 million during Q4 2023, and registered a low of $756.0 million during Q2 2025.
  • For the 5-year period, Haemonetics' Other Gross PP&E Adjustments averaged around $879.7 million, with its median value being $889.3 million (2022).
  • Per our database at Business Quant, Haemonetics' Other Gross PP&E Adjustments skyrocketed by 863.7% in 2023 and then plummeted by 1687.72% in 2025.
  • Haemonetics' Other Gross PP&E Adjustments (Quarter) stood at $817.3 million in 2021, then rose by 6.35% to $869.1 million in 2022, then rose by 11.27% to $967.1 million in 2023, then decreased by 11.65% to $854.5 million in 2024, then fell by 3.51% to $824.5 million in 2025.
  • Its Other Gross PP&E Adjustments was $824.5 million in Q4 2025, compared to $790.4 million in Q3 2025 and $756.0 million in Q2 2025.